ASR Vermogensbeheer’s Bristol-Myers Squibb BMY Stock Holding History

ASR Vermogensbeheer’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27M	Buy	468,931 +232,072	+98%	+$13.3M	0.28%	70
2026 Q1	$14.4M	Buy	236,859 +4,490	+2%	+$262K	0.17%	126
2025 Q4	$12.5M	Sell	232,369 -2,047	-0.9%	-$98.5K	0.15%	136
2025 Q3	$10.6M	Sell	234,416 -988	-0.4%	-$46.1K	0.13%	145
2025 Q2	$10.9M	Sell	235,404 -902	-0.4%	-$44.3K	0.14%	138
2025 Q1	$14.4M	Buy	+236,306	New	+$13.8M	0.21%	103

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

ASR Vermogensbeheer's BMY Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Bristol-Myers Squibb (BMY) stake by 98% in Q2 2026, buying an estimated $13.3M and bringing the position to 468,931 shares worth $27M. The position accounts for 0.28% of the portfolio, ranked #70.

ASR Vermogensbeheer first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. 824 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

ASR Vermogensbeheer held 468,931 shares of Bristol-Myers Squibb worth $27M as of Q2 2026.
ASR Vermogensbeheer bought 232,072 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.3M.
Bristol-Myers Squibb made up 0.28% of ASR Vermogensbeheer's portfolio in Q2 2026, its #70 holding.
ASR Vermogensbeheer first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
824 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.